Sign Up to like & get recommendations! 2
Published in 2023 at "United European Gastroenterology Journal"
DOI: 10.1002/ueg2.12365
Abstract: Abstract Background We aimed to investigate the efficacy of postoperative adjuvant transarterial chemoembolisation (PA‐TACE) in patients with hepatocellular carcinoma (HCC) complicated by microvascular invasion (MVI). Methods A retrospective analysis of 1505 patients with HCC who… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-019-01479-x
Abstract: To clarify the frequency and predictors of detecting early locoregional recurrence/disease progression (LR/DP) during the interval between surgery and postoperative adjuvant radiotherapy with/without chemotherapy in patients with oral squamous cell carcinoma. Data on 65 patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2019.100513
Abstract: BACKGROUND Given the growing evidence that sarcopenia and inflammation influence the survival of patients with cancer, we evaluated the prognostic significance of the skeletal muscle index (SMI) combined with an inflammation marker in patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Applied neuropsychology. Adult"
DOI: 10.1080/23279095.2022.2048830
Abstract: Infiltrative non-GBM gliomas are common primary intracranial malignancies, and postoperative adjuvant radiotherapy is recommended for most adult patients diagnosed with this disease to enhance local control and prolong intracranial progression-free survival (PFS). However, RT-related neurocognitive… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15632
Abstract: To compare survival outcomes of different postoperative adjuvant therapies (PATs) for early‐stage cervical cancer (ECC) patients with one intermediate‐risk pathological factor (IPF). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.15768
Abstract: Abstract Background Toceranib phosphate (TOC) could be made widely available for treating tumors in dogs if evidence shows that TOC inhibits recurrence after surgery. Objectives To investigate how postoperative adjuvant treatment with TOC modulates the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2021-002528
Abstract: Early stage cervical cancer, stages IB1–2 and IIA1, can be treated with (chemo)radiation and brachytherapy or radical hysterectomy with or without further adjuvant (chemo)radiation. In a carefully selected cohort for surgery, traditionally a small proportion… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Chemotherapy"
DOI: 10.1159/000524077
Abstract: Introduction: Data on the clinical outcomes of patients receiving adjuvant chemotherapy for surgically resected high-grade pulmonary neuroendocrine carcinoma (HGNEC) (large-cell neuroendocrine carcinoma and small-cell lung cancer) are limited. This study aimed to evaluate the prognostic… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Acta Radiologica"
DOI: 10.1177/0284185119878357
Abstract: Background Microvascular invasion has been widely accepted as a major risk factor of hepatocellular carcinoma prognoses after surgery. It is still controversial whether postoperative adjuvant transarterial chemoembolization could improve the survival of hepatocellular carcinoma patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "BMC Cancer"
DOI: 10.1186/s12885-020-07087-7
Abstract: Background Microvascular invasion (MVI) is considered to be one of the important prognostic factors that affect postoperative recurrence in patients with hepatocellular carcinoma (HCC) with variable results across their treatment options. This study was carried… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Trials"
DOI: 10.1186/s13063-017-2103-4
Abstract: BackgroundAs the toxicity associated with the α-GalCer-pulsed dendritic cell (DC) therapy could be considered to be negligible, its addition to postoperative adjuvant chemotherapy would be expected to greatly improve the therapeutic effect, and could result… read more here.